Tazorac and Nasopharyngitis - a phase IV clinical study of FDA data

Summary:

Nasopharyngitis is reported as a side effect among people who take Tazorac (tazarotene), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Pepcid, and have Vitiligo.

The phase IV clinical study analyzes which people have Nasopharyngitis when taking Tazorac. It is created by eHealthMe based on reports of 1,001 people who have side effects when taking Tazorac from the FDA, and is updated regularly.

What is Tazorac?

Tazorac has active ingredients of tazarotene. It is often used in acne. eHealthMe is studying from 1,046 Tazorac users. Check the latest studies of Tazorac.

What is Nasopharyngitis?

Nasopharyngitis (inflammation of the nasopharynx) is found to be associated with 2,439 drugs and 2,241 conditions by eHealthMe. Check the latest studies of Nasopharyngitis.

On Jul, 17, 2026

1,001 people reported to have side effects when taking Tazorac.
Among them, 23 people (2.3%) have Nasopharyngitis.

Among these 23 people:

How long have people been on Tazorac when they have Nasopharyngitis? *

What is the gender of people who have Nasopharyngitis when taking Tazorac? *

female: 86.36 %
male: 13.64 %

What is the age of people who have Nasopharyngitis when taking Tazorac? *

What are other drugs people take besides Tazorac? *

What are other side effects people have besides Nasopharyngitis? *

Pain: 11 people, 47.83%
Rashes (redness): 11 people, 47.83%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 10 people, 43.48%
Neck Pain: 10 people, 43.48%
Toothaches (tooth pain): 10 people, 43.48%
Hair Loss: 9 people, 39.13%
Osteopenia (a condition where bone mineral density is lower than normal): 9 people, 39.13%
Mood Swings (an extreme or rapid change in mood): 9 people, 39.13%
Metastatic Neoplasm (spreadable cancer tumour): 9 people, 39.13%
Menopause (end of monthly cycles in women): 9 people, 39.13%

What are the existing conditions these people have? *

Vitiligo (pigment is lost from areas of the skin): 9 people, 39.13%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 13.04%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 8.70%
Hypertrophic Cardiomyopathy (a condition in which the heart muscle becomes abnormally thick): 2 people, 8.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.70%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.35%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 4.35%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 4.35%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Tazorac and have Nasopharyngitis?

- Check whether Nasopharyngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazorac:

Tazorac (1,046 reports)

Nasopharyngitis treatments and more:

Nasopharyngitis (239,332 reports)

Browse all side effects of Tazorac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nasopharyngitis:

Nasopharyngitis (2,439 drugs)

Browse all the conditions that are associated with Nasopharyngitis:

Nasopharyngitis (2,241 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tazarotene (the active ingredients of Tazorac) and Tazorac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.